Methadone

Gender disparities in opioid treatment progress in methadone versus counselling

Citation
Guerrero, E., Amaro, H., Kong, Y. et al. Gender disparities in opioid treatment progress in methadone versus counseling. Subst Abuse Treat Prev Policy 16, 52 (2021). https://doi.org/10.1186/s13011-021-00389-4
Publication Date

The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies.

Plausibility of patient-centred care in high-intensity methadone treatment: Reflections of providers and patients

Citation
Marshall, K., Maina, G. & Sherstobitoff, J. Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients. Addict Sci Clin Pract 16, 42 (2021). https://doi.org/10.1186/s13722-021-00251-9
Publication Date

Abstract

Background: Patients with opioid use disorder (OUD) often have complex health care needs. Methadone is one of the medications for opioid use disorder (MOUD) used in the management of OUDs. Highly restrictive methadone treatment—which requires patient compliance with many rules of care—often results in low retention, especially if there is inadequate support from healthcare providers (HCPs).

Take-Home Dosing Experiences among Persons Receiving Methadone Maintenance Treatment during COVID-19

Citation
Figgatt, M. C., Salazar, Z., Day, E., Vincent, L., & Dasgupta, N. (2021). Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. Journal of Substance Abuse Treatment, 123, 108276.

Abstract

Purpose

Methadone maintenance treatment is a life-saving treatment for people with opioid use disorders (OUD). The coronavirus pandemic (COVID-19) has introduced many concerns surrounding access to opioid treatment. In March 2020, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued guidance allowing for the expansion of take-home methadone doses.

Cannabis Use during Methadone Maintenance Treatment for Opioid Use Disorder: A Systematic Review and Meta-Analysis

Citation
CMAJ Open 2019. DOI:10.9778/cmajo.20190026
Publication Date

Abstract

Background: Rates of cannabis use among patients receiving methadone maintenance therapy are high, and cannabis use may be associated with outcomes of methadone maintenance therapy. We examined the effect of cannabis use on opioid use in patients receiving methadone maintenance therapy to test the hypothesis that cannabis use is associated with a reduction in opioid use.

Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions

Citation
Connery, Hilary Smith, Harvard Review of Psychiatry. 23(2):63-75, March/April 2015.
Publication Date

This article is a review and analysis of past research that finds substantial evidence for the positive results of Medication-assisted treatment (MAT) in treating Opioid Use Disorder.

 

image <https://www.samhsa.gov/medication-assisted-treatment>

Effectiveness Bank Analysis: Therapy ‘Toolbox’ Helps Rescue Poorly Recovering Patients at London Maintenance Clinic

Citation
Lancet Psychiatry: 2019, 6, p. 391-402.
Publication Date

Instead of a set programme, a clinic in London tried offering patients prescribed methadone or buprenorphine but still using heroin or cocaine a selection from a suite of well-supported psychological interventions tailored to the patient, and then systematically re-tailored in the light of how they responded.

Drug-Induced Prolonged Corrected QT Interval in Patients with Methadone and Opium Overdose

Citation
Soroosh et al. Substance Abuse Treatment, Prevention, and Policy (2019) 14:8 https://doi.org/10.1186/s13011-019-0196-3
Publication Date

Abstract

Background

Iran is a country with the highest rate of opioid addiction in the world. The most commonly used opioid in Iran is opium, and methadone is in second place. The trend of drug use has changed from opium to methadone from 2006 to 2011. Presence of a large number of addicted people and methadone maintenance therapy clinics make methadone readily available in Iran.

Change, Grow, Live Medication-Assisted Treatments Toolkit

Created by
Change, Grow, Live
Publication Date

Drug-related deaths are the highest they have ever been. We know that medication-assisted treatments (MAT), such as the prescription of methadone and buprenorphine, are our most powerful interventions. Supporting opioid-dependent service users to begin MAT at the earliest and safest opportunity saves lives.